Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional)
Status: Open
- Who can apply
- Nonprofits, small businesses, state, local and tribal governments, tribes, schools and universities, for-profit companies, others.
- Deadline
- Friday, June 16, 2028 - check the notice for the exact time
- Opened Aug 31, 2026
- Amount
- Not stated by the source
- Official source
- Read and apply at the official source Found on grants.gov
- Requirements
- Documents with the official notice: PAR-27-053-Full-Announcement.html
- Organizations need a SAM.gov ID number (UEI) to apply. Individuals do not.
- Application fee
- We do not read fees from notices; check the official notice. GrantsWindow never charges you.
- Funder
- National Institutes of Health (federal)
- Assistance Listing 93.279
- Last checked
- Checked Nov 15, 2026 at the official source
From the official notice
This notice of funding opportunity (NOFO) uses a R61/R33 Phased Innovation Award activity code to support clinical research applications that are exploratory and developmental in nature and focus on understanding the neurobiological mechanisms underlying substance use disorders (SUD), including ...